Pan-Chyr Yang

USPTO Granted Patents = 31 (Patent Applications = 9)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 53(Granted Patents)

Company Filing History:

21 out of 1,349

National Taiwan University

National Health Research Institutes

patents

5. 1 out of 19

Taichung Veterans General Hospital

patents

6. 1 out of 122

National Chung Hsing University

patents

7. 1 out of 1,274

The University of North Carolina at Chapel Hill

patents

8. 1 out of 1,201

National Yang Ming Chiao Tung University

patents

9. 1 out of 135

Taipei Medical University

patents

10. 1 out of 832,961

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2024

Loading Chart...

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12109207 - Methods of using 4(1)-quinolone derivatives (2024-10-08),

2. 12085570 - Biomarkers for lung cancer stem cells (2024-09-10),

3. 12013513 - Metasurface based device for generating abrupt autofocusing beam (2024-06-18),

4. 11919886 - 4,9-dioxo-4,9-dihydronaphtho[2,3-B]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases (2024-03-05),

5. 11891447 - Method for treating cancer using CD14 antagonists (2024-02-06),

6. 11834682 - Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness (2023-12-05),

7. 11638705 - 4(1H)-quinolone derivatives and uses thereof (2023-05-02),

8. 11447778 - TNF-targeting aptamers and uses thereof for treatment or diagnosing TNF-related inflammatory diseases (2022-09-20),

9. 11434229 - 4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases (2022-09-06),

10. 11214774 - PINK1 C-terminal domain polypeptide and methods using the same in cancer treatment (2022-01-04),

11. 10888568 - Pharmaceutical composition for treatment of cancer using phenothiazine (2021-01-12),

12. 10865388 - Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness (2020-12-15),

13. 10765681 - Purine compounds possessing anticancer activity (2020-09-08),

14. 10584341 - Antagonistic PDL1 aptamers and their applications in cancer therapy (2020-03-10),

15. 10533179 - Antagonistic CTLA-4 aptamers and applications thereof in enhancing immune activity (2020-01-14),

Title: The Innovative Journey of Pan-Chyr Yang

Introduction: Pan-Chyr Yang, a distinguished inventor hailing from Taipei, Taiwan, has made significant contributions to the field of innovation with his groundbreaking work in various patents.

Latest Patents: Pan-Chyr Yang's recent patents focus on cutting-edge technologies in the healthcare sector, particularly in the development of advanced medical devices for early disease detection and treatment.

Career Highlights: With a career spanning over two decades, Pan-Chyr Yang has established himself as a leading figure in the innovation landscape. His pioneering research has led to the creation of several revolutionary products that have transformed the industry.

Collaborations: Throughout his career, Pan-Chyr Yang has collaborated with top research institutions, universities, and companies worldwide to further his inventions. His partnerships have been instrumental in bringing his visionary ideas to life.

Conclusion: Pan-Chyr Yang's relentless pursuit of innovation and his commitment to pushing the boundaries of technology have solidified his position as a trailblazer in the world of inventors. His work continues to inspire future generations of innovators to think outside the box and create solutions that shape the world we live in.

This text is generated by artificial intelligence and may not be accurate.